SEFFALAIR SPIROMAX pdr inh 232/14 mcg 60 dos
7680678910035
CH-67891
R03AK06
03.04.3.
Active substances:
1 / 2
google
Details
- Product number
- 6789103
- CPT
- -
- Packaging group
- 60
- Unit
- Stück
- Composition
- fluticasoni propionas 202 µg, salmeterolum 12.75 µg ut salmeteroli xinafoas, lactosum monohydricum ad pulverem pro dosi, doses pro vase 60.
Articles (1)
Seffalair Spiromax 232/14 mcg, Multidosenpulverinhalator
Multidosenpulverinhalator
60
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fluticasoni propionas
|
202.0 UG | Substance | Wirkstoff (Principe actif) |
|
salmeterolum
|
12.75 UG | Substance | Wirkstoff (Principe actif) |
|
salmeteroli xinafoas
|
- | Substance | WIZUS |
|
lactosum monohydricum
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 76.75
Specialties list
Yes
Generic
No
SL addition date:
01/10/2021
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67891
- Drug name
- Seffalair Spiromax, Multidosenpulverinhalator
- Galenic form
- PULIN
- ATC Code
- R03AK06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 12/04/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SEFFALAIR SPIROMAX pdr inh 232/14 mcg 60 dos
- Description (DE)
- SEFFALAIR SPIROMAX Inh Plv 232/14 mcg 60 Dos
- Market launch
- 12/04/2021
- Narcotic (BTM)
- No